MetaCap

Pharming Group N.V. ADS Company Profile

NASDAQ: PHARHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.54-0.62 (-5.10%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Pharming Group N.V. at a glance

Pharming Group N.V. ADS (NASDAQ: PHAR) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Leiden, Netherlands. Pharming Group N.V. is led by Mr. Kenneth Lynard EMBA, M.Sc. and employs about 407 people. At a market capitalization of $816.8 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001828316, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Pharming Group N.V. do?

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kd inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3Kd inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Business description based on the company's public filings.

Company information

Legal name
Pharming Group N.V. ADS
Ticker
NASDAQ: PHAR
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Kenneth Lynard EMBA, M.Sc.
Employees
407
Headquarters
Darwinweg 24, Leiden, Netherlands
Phone
31 71 524 7400
Market cap
$816.78M
SEC CIK
0001828316

Companies similar to Pharming Group N.V.

PHAR peer companies
CompanyPrice% ChgMarket capCompare
CRVSCorvus Pharmaceuticals Inc.9.67-3.40%$815.69Mvs PHAR
VSTMVerastem Inc.6.33-7.73%$797.67Mvs PHAR
SNDXSyndax Pharmaceuticals Inc.8.72-4.49%$785.05Mvs PHAR
IRWDIronwood Pharmaceuticals Inc. Class A4.70-0.21%$778.09Mvs PHAR
MTRIMentari Therapeutics Inc.14.70-3.57%$856.94Mvs PHAR
LTGOLatigo Biotherapeutics Inc.13.00-1.81%$861.89Mvs PHAR
COLLCollegium Pharmaceutical Inc.24.72-1.94%$768.18Mvs PHAR
ORICOric Pharmaceuticals Inc.7.36-4.42%$764.94Mvs PHAR

Related